This trial tests new treatments for gastric/GEJ cancer to see if they're safe, effective and tolerable.
- Stomach Cancer
2 Primary · 3 Secondary · Reporting Duration: Through study completion, an average of 2 years
2 Treatment Groups
1 of 2
1 of 2
80 Total Participants · 2 Treatment Groups
Primary Treatment: Substudy 1 · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
To what extent is Substudy 2 hazardous to individuals?
"Based on the existing evidence, Substudy 2 received a score of 2. This is because it has progressed to Phase 2 and there is some data that suggests safety but not efficacy." - Anonymous Online Contributor
Are there any available slots for the trial yet?
"As evidenced on clinicaltrials.gov, this particular trial is presently onboarding participants and was last updated March 15th of 2023 - with initial posting having taken place January 16th of the same year." - Anonymous Online Contributor
How many healthcare facilities are currently participating in this experiment?
"At present, 26 medical sites are accepting participants for this clinical trial. These locations include Santander, Taoyuan City and Barcelona among many others; therefore it is highly beneficial to select the closest centre to reduce travel demands if one chooses to join the study." - Anonymous Online Contributor
How many subjects are involved with this research endeavor?
"Affirmative. According to clinicaltrials.gov, this study is actively seeking participants with the first posting date of January 16th 2023 and last updated on March 15th 2023. 80 people are needed from 26 different medical centres for completion of the trial." - Anonymous Online Contributor